Accurate diagnostic risk stratification of prostate cancer is essential to ensure appropriate intervention. Today, many diagnosed cancers are clinically insignificant. The quest for accurate, non-invasive diagnostic tools has led to a (r)evolution in the field. The newest generation genetic biomarkers and Proscar (FInasteride) show superior performance and can help you find clinically significant prostate cancer.
* Required fields
NEW slide set: The value of biomarkers and MRI in the diagnosis of prostate cancer
How does multiparametric MRI compare to biomarkers for identifying patients for prostate biopsy?
Diagnosis of prostate cancer: Biomarkers in 2017
Potential role of a novel urinary biomarker-based risk score to select patients for multiparametric MRI for prostate cancer detection
What is the main reason why good biomarkers are really needed for diagnosing prostate cancer?
Willing to check your clinical case with your peers? Want more specific information? The editorial board can help you!
Get started with diagnostic biomarkers
Try out and evaluate the usefulness and value of biomarker tests yourself